Antitrust Antitrust

Comment: Vifor Pharma disparagement case sees EU antitrust regulator break new ground

By Nicholas Hirst
  • 21 Jun 2022 11:54
  • 21 Jun 2022 11:54
With its new probe against Vifor Pharma, the EU's antitrust enforcer is heading into new territory: The concern that a dominant company may have abused its market power merely by spreading negative information about a rival.  

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Nicholas Hirst

Chief Correspondent

Nicholas covers EU merger review and antitrust investigations for Mlex in Brussels. He previously wrote about EU affairs for Politico Europe, European Voice and PaRR. After earning an LLM in European law from the College of Europe in Bruges, he spent a year working in the competition practice of a leading competition law firm in Brussels 2009-10. He graduated in modern European languages from Oxford University in 2006.

Discover MLex

Stay on top of global regulatory developments

Latest News